Notably, after dapagliflozin treatment in T2DM patients, Erythropoietin (EPO) levels still increased after 2 months, suggesting that elevated hematocrit is due to both diuretic-induced hemoconcentration and increased EPO [103]. This evidence concerns the gene EPO and type 2 diabetes mellitus.